Publications by authors named "M Wappett"

Claim this Profile
U
USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF.
Anamarija Jurisic, Pei-Ju Sung, Mark Wappett, Julien Daubriac, Ian T Lobb

Clin Transl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
surviveR: a flexible shiny application for patient survival analysis.
Tamas Sessler, Gerard P Quinn, Mark Wappett, Emily Rogan, David Sharkey

Sci Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development.
Natalie Page, Mark Wappett, Colin R O'Dowd, Martin O'Rourke, Gerald Gavory

Sci Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Proof-of-Concept for Topical Delivery of Novel Peptide ALM201 with Potential Usefulness for Treating Neovascular Eye Disorders.
Gideon Obasanmi, M Andrew Nesbit, Diego Cobice, Logan Mackay, Stuart McGimpsey, Mark Wappett

Ophthalmol Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes.
Gerard P Quinn, Tamas Sessler, Baharak Ahmaderaghi, Shauna Lambe, Harper VanSteenhouse, Mark Wappett

BMC Bioinformatics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis